Drug substance assay

Drug substance or active pharmaceutical ingredient calculation will give the anhydrous FLP in each sample. This may act as an additional confirmation of the sample purity, but considering sample concentration as it is prepared by the analyst. As such, FLP purity and drug substance assay should correspond, that is, subtracting purity and assay should be within a certain allowable percentage.

First, the concentration of UV-pure material in a sample is calculated by:

where

UVMain

Area of UV main peak (mAU*s)

c

y-intercept of least squares line (calibration curve)

m

slope of least squares line (calibration curve)

lv

sample injection volume (µL) 

Concentration (%)(w/w) is then calculated by:

where

Concentration (%)(w/w)

Concentration weight per weight

Vsample

Total volume of sample solution (mL)

Csample

Concentration of UV-pure material in sample (mg/mL)

MSPsample

MS Purity, expressed as decimal; determined by dividing MS Purity by UV Purity

Wtsample

Weight of sample in mg

S

Decimal fraction of sum of water, solvents, and sodium acetate, as applicable